Back to User profile » Professor Toshiyuki Someya
Papers published by Professor Toshiyuki Someya:
Association Between the Number of Remaining Teeth and Body Mass Index in Japanese Inpatients with Schizophrenia
Otake M, Ono S, Watanabe Y, Kumagai K, Matsuzawa K, Kasahara H, Ootake M, Sugai T, Someya T
Neuropsychiatric Disease and Treatment 2022, 18:2591-2597
Published Date: 7 November 2022
Identification of Bonding Difficulties in the Peripartum Period Using the Mother-to-Infant Bonding Scale-Japanese Version and Its Tentative Cutoff Points
Hashijiri K, Watanabe Y, Fukui N, Motegi T, Ogawa M, Egawa J, Enomoto T, Someya T
Neuropsychiatric Disease and Treatment 2021, 17:3407-3413
Published Date: 20 November 2021
Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women
Ogawa M, Watanabe Y, Motegi T, Fukui N, Hashijiri K, Tsuboya R, Sugai T, Egawa J, Araki R, Haino K, Yamaguchi M, Nishijima K, Enomoto T, Someya T
Neuropsychiatric Disease and Treatment 2021, 17:221-227
Published Date: 26 January 2021
Depression, Anxiety and Primiparity are Negatively Associated with Mother–Infant Bonding in Japanese Mothers
Motegi T, Watanabe Y, Fukui N, Ogawa M, Hashijiri K, Tsuboya R, Sugai T, Egawa J, Araki R, Haino K, Yamaguchi M, Nishijima K, Enomoto T, Someya T
Neuropsychiatric Disease and Treatment 2020, 16:3117-3122
Published Date: 14 December 2020
Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Ozeki Y, Okamoto K, Sagae T, Someya T
Neuropsychiatric Disease and Treatment 2020, 16:2229-2236
Published Date: 30 September 2020
Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study
Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T
Neuropsychiatric Disease and Treatment 2019, 15:2353-2363
Published Date: 19 August 2019
Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T
Neuropsychiatric Disease and Treatment 2016, 12:427-436
Published Date: 24 February 2016
Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population
Otsuka I, Watanabe Y, Hishimoto A, Boku S, Mouri K, Shiroiwa K, Okazaki S, Nunokawa A, Shirakawa O, Someya T, Sora I
Neuropsychiatric Disease and Treatment 2015, 11:1381-1393
Published Date: 2 June 2015